Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner

Clinical Immunology

Volumn 143, Issue 1, 2012, Pages 51-58

  Oomizu, Souichi ^a   Arikawa, Tomohiro ^a   Niki, Toshiro ^a   Kadowaki, Takeshi ^a   Ueno, Masaki ^a   Nishi, Nozomu ^b   Yamauchi, Akira ^a   Hirashima, Mitsuomi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Differentiation; Galectin 9; Regulation; Th17; Tim 3; Treg

Indexed keywords

BENZYL DERIVATIVE; ECALECTIN; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; MEMBRANE PROTEIN; SWAINSONINE; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING MOLECULE 3; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IN VITRO STUDY; INFLAMMATION; INHIBITION KINETICS; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH17 CELL; UPREGULATION;

ACETYLGALACTOSAMINE; ANIMALS; BENZYL COMPOUNDS; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GALECTINS; INTERLEUKIN-17; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, VIRUS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84858081337     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.01.004     Document Type: Article

References (35)

1. Wada J., Kanwar Y.S. Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. J. Biol. Chem. 1997, 272:6078-6086.
2. Matsumoto R., Matsumoto H., Seki M., Hata M., Asano Y., Kanegasaki S., Stevens R.L., Hirashima M. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J. Biol. Chem. 1998, 273:16976-16984.
3. Tsuboi Y., Abe H., Nakagawa R., Oomizu S., Watanabe K., Nishi N., Nakamura T., Yamauchi A., Hirashima M. Galectin-9 protects mice from the Schwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes. Clin. Immunol. 2007, 124:221-233.
4. Nobumoto A., Oomizu S., Arikawa T., katoh S., Nagahara K., Miyake M., Nishi N., Takeshita K., Niki T., Yamauchi A., Hirashima M. Galectin-9 expands unique macrophages exhibiting lasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice. Clin. Immunol. 2009, 130:322-330.
5. Kashio Y., Nakamura K., Abedin M.J., Seki M., Nishi N., Yoshida N., Nakamura T., Hirashima M. Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J. Immunol. 2003, 170:3631-3636.
6. Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., Zheng X.X., Strom T.B., Kuchroo V.K. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 2005, 6:1245-1252.
7. Nagahara K., Arikawa T., Oomizu S., Kontani K., Nobumoto A., Tateno H., Watanabe K., Niki N., Katoh T.S., Miyake M., Nagahata S., Hirabayashi J., Kuchroo V.K., Yamauchi A., Hirashima M. Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. J. Immunol. 2008, 181:7660-7669.
8. Anderson A.C., Anderson D.E., Bregoli L., Hastings W.D., Kassam N., Lei C., Chandwaskar R., Karman J., Su E.W., Hirashima M., Bruce J.N., Kane L.P., Kuchroo V.K., Hafler D.A. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007, 318:1141-1143.
9. Dai S.Y., Nakagawa R., Itoh A., Murakami H., Kashio Y., Abe H., Katoh S., Kontani K., Kihara M., Zhang S.L., Hata T., Nakamura T., Yamauchi A., Hirashima M. Galectin-9 induces maturation of human monocyte-derived dendritic cells. J. Immunol. 2005, 175:2974-2981.
10. Jayaraman P., Sada-Ovalle I., Beladi S., Anderson A.C., Dardalhon V., Hotta C., Kuchroo V.K., Behar S.M. Tim-3 binding to galectin-9 stimulates antimicrobial immunity. J. Exp. Med. 2010, 207:2343-2354.
11. Liu F.T., Rabinovich G.A. Galectins: regulators of acute and chronic inflammation. Ann. N. Y. Acad. Sci. 2010, 1183:158-182.
12. Seki M., Oomizu S., Sakata K., Sakata A., Arikawa T., Watanabe K., Ito K., Takeshita K., Niki T., Saita N., Nishi N., Yamauchi A., Katoh S., Matsukawa A., Kuchroo V.K., Hirashima M. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 2008, 127:78-88.
13. Nakae S., Iwakura Y., Suto H., Galli S.J. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J. Leukoc. Biol. 2007, 81:1258-1268.
14. Niki T., Tsutsui S., Hirose S., Aradono S., Sugimoto Y., Takeshita K., Nishi N., Hirashima M. Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation. J. Biol. Chem. 2009, 284:32344-32352.
15. Katoh S., Ishii N., Nobumoto A., Takeshita K., Dai S.Y., Shinonaga R., Niki T., Nishi N., Tominaga A., Yamauchi A., Hirashima M. Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am. J. Respir. Crit. Care Med. 2007, 176:27-35.
16. Nobumoto A., Nagahara K., Oomizu S., Katoh S., Nishi N., Takeshita K., Niki T., Tominaga A., Yamauchi A., Hirashima M. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices. Glycobiology 2008, 18:735-744.
17. Su E.W., Bi S., Kane L.P. Galectin-9 regulates T helper cell function independently of Tim-3. Glycobiology 2011, 21:1258-1265.
18. Nishi N., Itoh A., Fujiyama A., Yoshida N., Araya S., Hirashima M., Shoji H., Nakamura T. Development of highly stable form of galectins: truncation of the linker peptide confers protease-resistant on tandem-repeat type galectins. FEBS Lett. 2005, 579:2058-2064.
19. Miller S.A., Weinmann A.S. Common themes emerge in the transcriptional control of T helper and developmental cell fate decisions regulated by the T-box, GATA and ROR families. Immunology 2009, 126:306-315.
20. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
21. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., Blank R.B., Meylan F., Siegel R., Henninghausen L., Shevach E.M., O'shea J.J. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
22. Lu L.H., Nakagawa R., Kashio Y., Itoh A., Shoji H., Nishi N., Hirashima M., Yamauchi A., Nakamura T. Characterization of galectin-9-induced death of Jurkat cells. J. Biochem. 2007, 141:157-172.
23. Voo K.S., Wang Y.-H., Santori F.R., Boggiano C., Wang Y.-H., Arima K., Bover L., Hanabuchi S., Khalili J., Marinova E., Zheng B., Littman D.R., Liu Y.-J. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4793-4798.
24. Kryczeki I., Wu K., Zhao E., Wei S., Vatan L., Szeliga W., Huang E., Greenson J., Chang A., Rolinski J., Radwan P., Fang J., Wang G., Zou W. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J. Immunol. 2011, 186:4388-4395.
25. Zorn E., Nelson E.A., Mohseni M., Porcheray F., Kim H., Litsa D., Bellucci R., Raderschall E., Canning C., Soiffe R.J., et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 2006, 108:1571-1579.
26. Zhou L., Ivanov I.I., Spolski R., Min R., Shenderov K., Egawa T., Levy D.E., Leonard W.J., Littman D.R. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 2007, 8:967-974.
27. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., Schluns K., Tian Q., Watowich S.S., Jetten A.M., Dong C. Essential autocrine regulation by IL-21 ion the generation of inflammatory T cells. Nature 2007, 448:480-483.
28. Korn T., Bettelli E., Gau W., Awasthi A., Jager A., Storm T.B., Oukka M., Kuchroo V.K. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448:484-487.
29. Wiersma V.R., de Bruyn M., Helfrich W., Bremer E. Therapeutic potential of galectin-9 in human disease. Med. Res. Rev. 2011, 10.1002/med.20249.
30. Zhu C., Anderson A.C., Kuchroo V.K. TIM-3 and its regulatory role in immune responses. Curr. Top. Microbiol. Immunol. 2011, 350:1-15.
31. He W., Fang Z., Wang F., Wu K., Xu Y., Zhou H., Du D., Gao Y., Zhang W.N., Niki T., Hirashima M., Yuan J., Chen Z.K. Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice. Transplantation 2009, 88:782-790.
32. Sakai K., Kawata E., Ashihara E., Nakagawa Y., Yamauchi A., Yao H., Nagao R., Tanaka R., Yokota A., Takeuchi M., Hirai H., Kimura S., Hirashima M., Yoshimura N., Maekawa T. Galectin-9 ameliorates acute GVH disease through the induction of T cell apoptosis. Eur. J. Immunol. 2011, 41:67-75.
33. Arikawa T., Saita N., Oomizu S., Ueno M., Matsukawa M., Katoh S., Kojima K., Nagahara K., Miyake M., Yamauchi A., Kohrogi H., Hirashima M. Galectin-9 expands immunosuppressive macrophages to ameliorate T cell-mediated lung inflammation. Eur. J. Immunol. 2010, 40:548-558.
34. Dardalhon V., Anderson A.C., Karman J., Apetoh L., Chandwaskar R., Lee D.H., Cornejo M., Nishi N., Yamauchi A., Quintana F.J., Sobel R.A., Hirashima M., Kuchroo V.K. Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. J. Immunol. 2010, 185:1383-1392.
35. Kojima K., Arikawa T., Saita N., Goto E., Tsumura S., Tanaka R., Masunaga A., Niki T., Oomizu S., Hirashima M., Kohrogi H. Galectin-9 attenuates acute lung injury by expanding CD14-plasmacytoid dendritic cell-like macrophages. Am. J. Respir. Crit. Care Med. 2011, 184:328-339.